Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Growth (Status and Outlook) 2024-2031

Report ID: 1503163 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2028
        2.1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type
        2.2.1 SX-PCK9
        2.2.2 O-304
        2.2.3 K-312
        2.2.4 BLSM-201
        2.2.5 DCRPCSK-9
        2.2.6 Others
    2.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type
        2.3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    2.4 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Application
        2.4.1 Cardiovascular Disease
        2.4.2 Homozugous Familial Hyperchalesterolemia
        2.4.3 Liver Disease
        2.4.4 Metabolic Syndrome
        2.4.5 Others
    2.5 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application
        2.5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Player
    3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Players
        3.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Players (2020-2022)
        3.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Players (2020-2022)
    3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Proprotein Convertase Subtilisin/Kexin Type 9 by Regions
    4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Regions (2017-2022)
    4.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)
    4.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)
    4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)
    4.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022)
    5.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)
    5.3 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022)
    6.2 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)
    6.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 by Country (2017-2022)
    7.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)
    7.3 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 by Region (2017-2022)
    8.2 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022)
    8.3 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
    10.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Regions (2023-2028)
        10.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Regions (2023-2028)
        10.1.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Forecast
        10.1.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Forecast
        10.1.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast
        10.1.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Forecast
    10.2 Americas Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Country (2023-2028)
        10.2.1 United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.2.2 Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.2.3 Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.2.4 Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
    10.3 APAC Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Region (2023-2028)
        10.3.1 China Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.3.2 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.3.3 Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.3.4 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.3.5 India Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.3.6 Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
    10.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Country (2023-2028)
        10.4.1 Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.4.2 France Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.4.3 UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.4.4 Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.4.5 Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
    10.5 Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Region (2023-2028)
        10.5.1 Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.5.2 South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.5.3 Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.5.4 Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
        10.5.5 GCC Countries Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast
    10.6 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Type (2023-2028)
    10.7 Global Proprotein Convertase Subtilisin/Kexin Type 9 Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 AFFiRiS AG
        11.1.1 AFFiRiS AG Company Information
        11.1.2 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 AFFiRiS AG Main Business Overview
        11.1.5 AFFiRiS AG Latest Developments
    11.2 Betagenon AB
        11.2.1 Betagenon AB Company Information
        11.2.2 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Betagenon AB Main Business Overview
        11.2.5 Betagenon AB Latest Developments
    11.3 Bioleaders Corp
        11.3.1 Bioleaders Corp Company Information
        11.3.2 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Bioleaders Corp Main Business Overview
        11.3.5 Bioleaders Corp Latest Developments
    11.4 BioLingus AG
        11.4.1 BioLingus AG Company Information
        11.4.2 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 BioLingus AG Main Business Overview
        11.4.5 BioLingus AG Latest Developments
    11.5 Catabasis Pharmaceuticals Inc
        11.5.1 Catabasis Pharmaceuticals Inc Company Information
        11.5.2 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Catabasis Pharmaceuticals Inc Main Business Overview
        11.5.5 Catabasis Pharmaceuticals Inc Latest Developments
    11.6 Dicerna Pharmaceuticals Inc
        11.6.1 Dicerna Pharmaceuticals Inc Company Information
        11.6.2 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Dicerna Pharmaceuticals Inc Main Business Overview
        11.6.5 Dicerna Pharmaceuticals Inc Latest Developments
    11.7 Eli Lilly and Co
        11.7.1 Eli Lilly and Co Company Information
        11.7.2 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.7.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Eli Lilly and Co Main Business Overview
        11.7.5 Eli Lilly and Co Latest Developments
    11.8 Ensemble Therapeutics Corp
        11.8.1 Ensemble Therapeutics Corp Company Information
        11.8.2 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Ensemble Therapeutics Corp Main Business Overview
        11.8.5 Ensemble Therapeutics Corp Latest Developments
    11.9 Kowa Co Ltd
        11.9.1 Kowa Co Ltd Company Information
        11.9.2 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Kowa Co Ltd Main Business Overview
        11.9.5 Kowa Co Ltd Latest Developments
    11.10 Novartis AG
        11.10.1 Novartis AG Company Information
        11.10.2 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Novartis AG Main Business Overview
        11.10.5 Novartis AG Latest Developments
    11.11 Pfizer Inc
        11.11.1 Pfizer Inc Company Information
        11.11.2 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.11.3 Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 Pfizer Inc Main Business Overview
        11.11.5 Pfizer Inc Latest Developments
    11.12 Regeneron Pharmaceuticals Inc
        11.12.1 Regeneron Pharmaceuticals Inc Company Information
        11.12.2 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.12.3 Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Regeneron Pharmaceuticals Inc Main Business Overview
        11.12.5 Regeneron Pharmaceuticals Inc Latest Developments
    11.13 Serometrix LLC
        11.13.1 Serometrix LLC Company Information
        11.13.2 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.13.3 Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Serometrix LLC Main Business Overview
        11.13.5 Serometrix LLC Latest Developments
    11.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
        11.14.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Company Information
        11.14.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.14.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Main Business Overview
        11.14.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Latest Developments
    11.15 The Medicines Company
        11.15.1 The Medicines Company Company Information
        11.15.2 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
        11.15.3 The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 The Medicines Company Main Business Overview
        11.15.5 The Medicines Company Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of SX-PCK9
    Table 3. Major Players of O-304
    Table 4. Major Players of K-312
    Table 5. Major Players of BLSM-201
    Table 6. Major Players of DCRPCSK-9
    Table 7. Major Players of Others
    Table 8. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 9. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)
    Table 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    Table 11. Proprotein Convertase Subtilisin/Kexin Type 9 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)
    Table 13. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
    Table 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Players (2020-2022) & ($ Millions)
    Table 15. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Player (2020-2022)
    Table 16. Proprotein Convertase Subtilisin/Kexin Type 9 Key Players Head office and Products Offered
    Table 17. Proprotein Convertase Subtilisin/Kexin Type 9 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 18. New Products and Potential Entrants
    Table 19. Mergers & Acquisitions, Expansion
    Table 20. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Regions 2017-2022 & ($ Millions)
    Table 21. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Regions (2017-2022)
    Table 22. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022) & ($ Millions)
    Table 23. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country (2017-2022)
    Table 24. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)
    Table 25. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    Table 26. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)
    Table 27. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
    Table 28. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022) & ($ Millions)
    Table 29. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region (2017-2022)
    Table 30. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)
    Table 31. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    Table 32. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)
    Table 33. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
    Table 34. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Country (2017-2022) & ($ Millions)
    Table 35. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country (2017-2022)
    Table 36. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)
    Table 37. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    Table 38. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)
    Table 39. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
    Table 40. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Region (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region (2017-2022)
    Table 42. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Type (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type (2017-2022)
    Table 44. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size by Application (2017-2022) & ($ Millions)
    Table 45. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application (2017-2022)
    Table 46. Key Market Drivers & Growth Opportunities of Proprotein Convertase Subtilisin/Kexin Type 9
    Table 47. Key Market Challenges & Risks of Proprotein Convertase Subtilisin/Kexin Type 9
    Table 48. Key Industry Trends of Proprotein Convertase Subtilisin/Kexin Type 9
    Table 49. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 50. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Regions (2023-2028)
    Table 51. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 52. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Type (2023-2028)
    Table 53. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 54. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share Forecast by Application (2023-2028)
    Table 55. AFFiRiS AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 56. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 57. AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 58. AFFiRiS AG Main Business
    Table 59. AFFiRiS AG Latest Developments
    Table 60. Betagenon AB Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 61. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 62. Betagenon AB Main Business
    Table 63. Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 64. Betagenon AB Latest Developments
    Table 65. Bioleaders Corp Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 66. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 67. Bioleaders Corp Main Business
    Table 68. Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 69. Bioleaders Corp Latest Developments
    Table 70. BioLingus AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 71. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 72. BioLingus AG Main Business
    Table 73. BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 74. BioLingus AG Latest Developments
    Table 75. Catabasis Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 76. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 77. Catabasis Pharmaceuticals Inc Main Business
    Table 78. Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 79. Catabasis Pharmaceuticals Inc Latest Developments
    Table 80. Dicerna Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 81. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 82. Dicerna Pharmaceuticals Inc Main Business
    Table 83. Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 84. Dicerna Pharmaceuticals Inc Latest Developments
    Table 85. Eli Lilly and Co Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 86. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 87. Eli Lilly and Co Main Business
    Table 88. Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 89. Eli Lilly and Co Latest Developments
    Table 90. Ensemble Therapeutics Corp Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 91. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 92. Ensemble Therapeutics Corp Main Business
    Table 93. Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 94. Ensemble Therapeutics Corp Latest Developments
    Table 95. Kowa Co Ltd Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 96. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 97. Kowa Co Ltd Main Business
    Table 98. Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 99. Kowa Co Ltd Latest Developments
    Table 100. Novartis AG Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 101. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 102. Novartis AG Main Business
    Table 103. Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. Novartis AG Latest Developments
    Table 105. Pfizer Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 106. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 107. Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 108. Pfizer Inc Main Business
    Table 109. Pfizer Inc Latest Developments
    Table 110. Regeneron Pharmaceuticals Inc Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 111. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 112. Regeneron Pharmaceuticals Inc Main Business
    Table 113. Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 114. Regeneron Pharmaceuticals Inc Latest Developments
    Table 115. Serometrix LLC Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 116. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 117. Serometrix LLC Main Business
    Table 118. Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 119. Serometrix LLC Latest Developments
    Table 120. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 121. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 122. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Main Business
    Table 123. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 124. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Latest Developments
    Table 125. The Medicines Company Details, Company Type, Proprotein Convertase Subtilisin/Kexin Type 9 Area Served and Its Competitors
    Table 126. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Product Offered
    Table 127. The Medicines Company Main Business
    Table 128. The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 129. The Medicines Company Latest Developments
List of Figures
    Figure 1. Proprotein Convertase Subtilisin/Kexin Type 9 Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021
    Figure 7. Proprotein Convertase Subtilisin/Kexin Type 9 in Cardiovascular Disease
    Figure 8. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Cardiovascular Disease (2017-2022) & ($ Millions)
    Figure 9. Proprotein Convertase Subtilisin/Kexin Type 9 in Homozugous Familial Hyperchalesterolemia
    Figure 10. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Homozugous Familial Hyperchalesterolemia (2017-2022) & ($ Millions)
    Figure 11. Proprotein Convertase Subtilisin/Kexin Type 9 in Liver Disease
    Figure 12. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Liver Disease (2017-2022) & ($ Millions)
    Figure 13. Proprotein Convertase Subtilisin/Kexin Type 9 in Metabolic Syndrome
    Figure 14. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Metabolic Syndrome (2017-2022) & ($ Millions)
    Figure 15. Proprotein Convertase Subtilisin/Kexin Type 9 in Others
    Figure 16. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market: Others (2017-2022) & ($ Millions)
    Figure 17. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021
    Figure 18. Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Player in 2021
    Figure 19. Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Regions (2017-2022)
    Figure 20. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)
    Figure 21. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)
    Figure 22. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)
    Figure 23. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2017-2022 ($ Millions)
    Figure 24. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Value Market Share by Country in 2021
    Figure 25. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Type in 2021
    Figure 26. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021
    Figure 27. United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 31. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region in 2021
    Figure 32. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021
    Figure 33. China Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 36. Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 37. India Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 38. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Country in 2021
    Figure 40. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021
    Figure 41. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021
    Figure 42. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 43. France Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 44. UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 45. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Region in 2021
    Figure 48. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Type in 2021
    Figure 49. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Market Share by Application in 2021
    Figure 50. Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 51. South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 52. Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 53. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 54. GCC Country Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Growth 2017-2022 ($ Millions)
    Figure 55. Americas Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 56. APAC Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 57. Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 58. Middle East & Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 59. United States Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 60. Canada Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 61. Mexico Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 62. Brazil Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 63. China Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 64. Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 65. Korea Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 66. Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 67. India Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 68. Australia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 69. Germany Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 70. France Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 71. UK Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 72. Italy Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 73. Russia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 74. Spain Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 75. Egypt Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 76. South Africa Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 77. Israel Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 78. Turkey Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
    Figure 79. GCC Countries Proprotein Convertase Subtilisin/Kexin Type 9 Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Proprotein Convertase Subtilisin/Kexin Type 9 Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports